MUSC Hollings Cancer Center Wins $1.4 Million for Breast Cancer Research
Grant Pairs Researchers from Hollings and Renowned Baylor College of Medicine
October 20, 2010, Charleston, SC – Researchers from the Hollings Cancer Center at the Medical University (MUSC) of South Carolina have won a $1.4 million grant from the US Department of Defense to enhance breast cancer research at MUSC.
The four-year grant, which partners Hollings researchers with a team from the Baylor College of Medicine in Houston, TX, establishes a breast cancer research training program here at MUSC called BRIDGE, or Breast Cancer Research Initiative for Developing Growth and Education, enabling young investigators from MUSC to be closely mentored by scientist from MUSC and Baylor College of Medicine, which is internationally-recognized for breast cancer research.
“In South Carolina, breast cancer is the most prevalent cancer – and also the second leading cause of cancer death – in women. And there are significant differences in how breast cancer affects African American- and Caucasian women,” said BRIDGE Principal Investigator Carola Neumann, MD, assistant professor of Cell & Molecular Pharmacology at MUSC. “This grant will allow us to work with some of the world’s most experienced breast cancer researchers. We will learn as much as we can so we can work on South Carolina’s breast cancer problems.”
The Hollings research team includes Victoria Findlay, PhD, and Erika Brown, PhD, both assistant professors of Pathology & Laboratory Medicine; Steven Rosenzweig, PhD, assistant director of Shared Resources at Hollings; Dennis Watson, PhD, program leader of the Cancer Genes and Molecular Regulation program at Hollings; Rita Kramer, MD, breast oncologist; Anthony Alberg, PhD, assistant director of Cancer Prevention and Control at Hollings; Marvella Ford, PhD, associate director for Cancer Disparities at Hollings at MUSC; and Michael Wyatt, PhD, of the University of South Carolina.
About Hollings Cancer Center at MUSC
Hollings Cancer Center at the Medical University of South Carolina is a National Cancer Institute-designated cancer center and the largest academic-based cancer program in South Carolina. The cancer center has more than $35M in cancer research funding and more than 1,000 people are currently participating on a cancer clinical trial at Hollings Cancer Center.
Hollings Cancer Center offers state-of-the-art diagnostic capabilities, therapies and surgical techniques and has multidisciplinary clinics that involve surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and many other specialists seeing patients under one roof. Multidisciplinary care is provided in disease specific clinics such as thoracic, breast, head & neck, genitourinary, gastrointestinal, hematological, and pediatric cancers. For more information, please visit: www.hcc.musc.edu <http://www.hcc.musc.edu> .